Goldman Sachs raised the firm’s price target on Gentex (GNTX) to $28 from $25 and keeps a Neutral rating on the shares following quarterly results. The firm believes this was solid report, and it is especially encouraged by the company’s gross margin improvement in the quarter driven by purchase cost reductions and operational efficiencies, which Goldman believes sets the company up well to reach its long-term gross margin target of 35%-36%.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GNTX:
- Gentex: Strong Performance with Margin Improvements, But Growth and Valuation Concerns Persist
- Gentex price target raised to $32 from $28 at B. Riley
- Gentex price target raised to $30 from $26 at Baird
- Gentex price target raised to $28 from $23 at UBS
- Gentex Corporation Reports Strong Q2 2025 Results